Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal

Total article views   HTML views PDF downloads Totals
10,802 Dovepress* 8,898+ 1,106 10,004
PubMed Central* 1,904 330 2,234
Totals 10,802 1,436 12,238
*Since 22 August 2018

View citations on PubMed Central and Google Scholar